Pulmocide Archives | Be Korea-savvy
Jeito Capital Strengthens Its Support in Pulmocide with Participation in $52 Million Financing

Jeito Capital Strengthens Its Support in Pulmocide with Participation in $52 Million Financing

Paris, France, Dec. 6 (Korea Bizwire) - Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company Pulmocide, a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory [...]

Jeito Capital Leads Oversubscribed $92 Million Series C Financing Round in Pulmocide

Jeito Capital Leads Oversubscribed $92 Million Series C Financing Round in Pulmocide

Paris, France, May 27 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, today announces that it has led an oversubscribed $92million Series C financing round in Pulmocide, a late-stage biopharmaceutical company developing novel therapies for patients suffering from serious acute and chronic respiratory diseases. Jeito led [...]